{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:38:46Z","timestamp":1792067926872,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis caused by Gram-positive bacterial pathogens is a major fatal disease but its molecular basis remains elusive. Toll-like receptor 2 (TLR2) has been implicated in the orchestration of inflammation and sepsis but its role appears to vary for different pathogen species and clones. Accordingly,\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    clinical isolates differ substantially in their capacity to activate TLR2. Here we show that strong TLR2 stimulation depends on high-level production of phenol-soluble modulin (PSM) peptides in response to the global virulence activator Agr. PSMs are required for mobilizing lipoproteins, the TLR2 agonists, from the staphylococcal cytoplasmic membrane. Notably, the course of sepsis caused by PSM-deficient\n                    <jats:italic>S. aureus<\/jats:italic>\n                    is similar in wild-type and TLR2-deficient mice, but TLR2 is required for protection of mice against PSM-producing\n                    <jats:italic>S. aureus<\/jats:italic>\n                    . Thus, a crucial role of TLR2 depends on agonist release by bacterial surfactants. Modulation of this process may lead to new therapeutic strategies against Gram-positive infections.\n                  <\/jats:p>","DOI":"10.1038\/ncomms12304","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T05:48:20Z","timestamp":1469771300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants"],"prefix":"10.1038","volume":"7","author":[{"given":"Dennis","family":"Hanzelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwang-Soo","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirita","family":"Franz-Wachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hertlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Macek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Wolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Peschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"BFncomms12304_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369, 840\u2013851 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms12304_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","volume":"72","author":"A Plociennikowska","year":"2015","unstructured":"Plociennikowska, A., Hromada-Judycka, A., Borzecka, K. & Kwiatkowska, K. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell. Mol. Life Sci. 72, 557\u2013581 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFncomms12304_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"BFncomms12304_CR4","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.4049\/jimmunol.177.5.3162","volume":"177","author":"M Hashimoto","year":"2006","unstructured":"Hashimoto, M. et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177, 3162\u20133169 (2006).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR5","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.4049\/jimmunol.165.10.5392","volume":"165","author":"O Takeuchi","year":"2000","unstructured":"Takeuchi, O., Hoshino, K. & Akira, S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165, 5392\u20135396 (2000).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0300060513504358","volume":"42","author":"I Nachtigall","year":"2014","unstructured":"Nachtigall, I. et al. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. J. Int. Med. Res. 42, 93\u2013110 (2014).","journal-title":"J. Int. Med. Res."},{"key":"BFncomms12304_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/infdis\/jiu080","volume":"210","author":"MH Stappers","year":"2014","unstructured":"Stappers, M. H. et al. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections. J. Infect. Dis. 210, 311\u2013318 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFncomms12304_CR8","doi-asserted-by":"publisher","first-page":"e65031","DOI":"10.1371\/journal.pone.0065031","volume":"8","author":"C Lachance","year":"2013","unstructured":"Lachance, C., Segura, M., Gerber, P. P., Xu, J. & Gottschalk, M. Toll-like receptor 2-independent host innate immune response against an epidemic strain of Streptococcus suis that causes a toxic shock-like syndrome in humans. PLoS ONE 8, e65031 (2013).","journal-title":"PLoS ONE"},{"key":"BFncomms12304_CR9","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.4049\/jimmunol.169.7.3869","volume":"169","author":"BT Edelson","year":"2002","unstructured":"Edelson, B. T. & Unanue, E. R. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169, 3869\u20133875 (2002).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR10","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1128\/IAI.01680-07","volume":"76","author":"TG Loof","year":"2008","unstructured":"Loof, T. G., Goldmann, O. & Medina, E. Immune recognition of Streptococcus pyogenes by dendritic cells. Infect. Immun. 76, 2785\u20132792 (2008).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR11","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.4049\/jimmunol.0804292","volume":"182","author":"M Schmaler","year":"2009","unstructured":"Schmaler, M. et al. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J. Immunol. 182, 7110\u20137118 (2009).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1128\/IAI.02832-14","volume":"83","author":"AG Peres","year":"2015","unstructured":"Peres, A. G. et al. Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus. Infect. Immun. 83, 1587\u20131597 (2015).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR13","doi-asserted-by":"publisher","first-page":"619410","DOI":"10.1155\/2014\/619410","volume":"2014","author":"AP Basto","year":"2014","unstructured":"Basto, A. P. & Leitao, A. Targeting TLR2 for vaccine development. J. Immunol. Res. 2014, 619410 (2014).","journal-title":"J. Immunol. Res."},{"key":"BFncomms12304_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L. & Fowler, V. G. Jr Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28, 603\u2013661 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFncomms12304_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrmicro3521","volume":"13","author":"V Thammavongsa","year":"2015","unstructured":"Thammavongsa, V., Kim, H. K., Missiakas, D. & Schneewind, O. Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13, 529\u2013543 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms12304_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev-micro-092412-155746","volume":"67","author":"AN Spaan","year":"2013","unstructured":"Spaan, A. N., Surewaard, B. G., Nijland, R. & van Strijp, J. A. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu. Rev. Microbiol. 67, 629\u2013650 (2013).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFncomms12304_CR17","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1111\/febs.12041","volume":"279","author":"H Nakayama","year":"2012","unstructured":"Nakayama, H., Kurokawa, K. & Lee, B. L. Lipoproteins in bacteria: structures and biosynthetic pathways. FEBS J. 279, 4247\u20134268 (2012).","journal-title":"FEBS J."},{"key":"BFncomms12304_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/femsre\/fuu006","volume":"39","author":"N Buddelmeijer","year":"2015","unstructured":"Buddelmeijer, N. The molecular mechanism of bacterial lipoprotein modification--how, when and why? FEMS Microbiol. Rev. 39, 246\u2013261 (2015).","journal-title":"FEMS Microbiol. Rev."},{"key":"BFncomms12304_CR19","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1128\/IAI.00538-10","volume":"78","author":"P Muller","year":"2010","unstructured":"Muller, P. et al. The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect. Immun. 78, 4243\u20134250 (2010).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fcimb.2012.00041","volume":"2","author":"JR Sheldon","year":"2012","unstructured":"Sheldon, J. R. & Heinrichs, D. E. The iron-regulated staphylococcal lipoproteins. Front. Cell. Infect. Microbiol. 2, 41 (2012).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"BFncomms12304_CR21","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1128\/IAI.73.4.2411-2423.2005","volume":"73","author":"H Stoll","year":"2005","unstructured":"Stoll, H., Dengjel, J., Nerz, C. & Gotz, F. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect. Immun. 73, 2411\u20132423 (2005).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mib.2013.11.004","volume":"17","author":"M Otto","year":"2014","unstructured":"Otto, M. Staphylococcus aureus toxins. Curr. Opin. Microbiol. 17, 32\u201337 (2014).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFncomms12304_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2217\/fmb.14.31","volume":"9","author":"R Singh","year":"2014","unstructured":"Singh, R. & Ray, P. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microbiol. 9, 669\u2013681 (2014).","journal-title":"Future Microbiol."},{"key":"BFncomms12304_CR24","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/nm1656","volume":"13","author":"R Wang","year":"2007","unstructured":"Wang, R. et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13, 1510\u20131514 (2007).","journal-title":"Nat. Med."},{"key":"BFncomms12304_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molcel.2008.08.005","volume":"32","author":"SY Queck","year":"2008","unstructured":"Queck, S. Y. et al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell. 32, 150\u2013158 (2008).","journal-title":"Mol. Cell."},{"key":"BFncomms12304_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrmicro3110","volume":"11","author":"A Peschel","year":"2013","unstructured":"Peschel, A. & Otto, M. Phenol-soluble modulins and staphylococcal infection. Nat. Rev. Microbiol. 11, 667\u2013673 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms12304_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2010.05.012","volume":"7","author":"D Kretschmer","year":"2010","unstructured":"Kretschmer, D. et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7, 463\u2013473 (2010).","journal-title":"Cell Host Microbe"},{"key":"BFncomms12304_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro3390","volume":"13","author":"DA Bloes","year":"2015","unstructured":"Bloes, D. A., Kretschmer, D. & Peschel, A. Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors. Nat. Rev. Microbiol. 13, 95\u2013104 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms12304_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1096\/fj.10-175208","volume":"25","author":"M Rautenberg","year":"2011","unstructured":"Rautenberg, M., Joo, H. S., Otto, M. & Peschel, A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 25, 1254\u20131263 (2011).","journal-title":"FASEB J."},{"key":"BFncomms12304_CR30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJMe058023","volume":"352","author":"HF Chambers","year":"2005","unstructured":"Chambers, H. F. Community-associated MRSA--resistance and virulence converge. N. Engl. J. Med. 352, 1485\u20131487 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms12304_CR31","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1128\/IAI.00046-11","volume":"79","author":"GY Cheung","year":"2011","unstructured":"Cheung, G. Y., Wang, R., Khan, B. A., Sturdevant, D. E. & Otto, M. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect. Immun. 79, 1927\u20131935 (2011).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR32","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1074\/jbc.M111.221382","volume":"286","author":"HS Joo","year":"2011","unstructured":"Joo, H. S., Cheung, G. Y. & Otto, M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J. Biol. Chem. 286, 8933\u20138940 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFncomms12304_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/infdis\/jit662","volume":"209","author":"BA Diep","year":"2014","unstructured":"Diep, B. A. et al. Identifying potential therapeutic targets of methicillin-resistant Staphylococcus aureus through in vivo proteomic analysis. J. Infect. Dis. 209, 1533\u20131541 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFncomms12304_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nm.3047","volume":"19","author":"SS Chatterjee","year":"2013","unstructured":"Chatterjee, S. S. et al. Essential Staphylococcus aureus toxin export system. Nat. Med. 19, 364\u2013367 (2013).","journal-title":"Nat. Med."},{"key":"BFncomms12304_CR35","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/IAI.68.5.2410-2417.2000","volume":"68","author":"CJ Vesy","year":"2000","unstructured":"Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J. & Munford, R. S. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68, 2410\u20132417 (2000).","journal-title":"Infect. Immun."},{"key":"BFncomms12304_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4049\/jimmunol.166.1.15","volume":"166","author":"AM Hajjar","year":"2001","unstructured":"Hajjar, A. M. et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166, 15\u201319 (2001).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR37","doi-asserted-by":"publisher","first-page":"568.e1","DOI":"10.1016\/j.cmi.2015.01.026","volume":"21","author":"F Valour","year":"2015","unstructured":"Valour, F. et al. Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation. Clin. Microbiol. Infect. 21, 568.e1\u2013568.e11 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFncomms12304_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00109-012-0926-8","volume":"90","author":"BW Bardoel","year":"2012","unstructured":"Bardoel, B. W. et al. Evasion of toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J. Mol. Med. (Berl) 90, 1109\u20131120 (2012).","journal-title":"J. Mol. Med. (Berl)"},{"key":"BFncomms12304_CR39","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.1073\/pnas.1502026112","volume":"112","author":"KJ Koymans","year":"2015","unstructured":"Koymans, K. J. et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3). Proc. Natl Acad. Sci. USA 112, 11018\u201311023 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms12304_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1473-3099(01)00095-0","volume":"1","author":"UR Hengge","year":"2001","unstructured":"Hengge, U. R., Benninghoff, B., Ruzicka, T. & Goos, M. Topical immunomodulators--progress towards treating inflammation, infection, and cancer. Lancet Infect. Dis. 1, 189\u2013198 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"BFncomms12304_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","volume":"4","author":"A Savva","year":"2013","unstructured":"Savva, A. & Roger, T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front. Immunol. 4, 387 (2013).","journal-title":"Front. Immunol."},{"key":"BFncomms12304_CR42","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1021\/es505803c","volume":"49","author":"LH Kim","year":"2015","unstructured":"Kim, L. H., Jung, Y., Yu, H. W., Chae, K. J. & Kim, I. S. Physicochemical interactions between rhamnolipids and pseudomonas aeruginosa biofilm layers. Environ. Sci. Technol. 49, 3718\u20133726 (2015).","journal-title":"Environ. Sci. Technol."},{"key":"BFncomms12304_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4049\/jimmunol.168.1.348","volume":"168","author":"RM Wooten","year":"2002","unstructured":"Wooten, R. M. et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168, 348\u2013355 (2002).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR44","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.4049\/jimmunol.1203305","volume":"191","author":"A Siegfried","year":"2013","unstructured":"Siegfried, A. et al. IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-alpha secretion and LPS-induced endotoxin shock. J. Immunol. 191, 3913\u20133921 (2013).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR45","doi-asserted-by":"publisher","first-page":"e1003016","DOI":"10.1371\/journal.ppat.1003016","volume":"8","author":"T Geiger","year":"2012","unstructured":"Geiger, T. et al. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog. 8, e1003016 (2012).","journal-title":"PLoS Pathog."},{"key":"BFncomms12304_CR46","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1074\/mcp.M113.035824","volume":"13","author":"A Carpy","year":"2014","unstructured":"Carpy, A. et al. Absolute proteome and phosphoproteome dynamics during the cell cycle of Schizosaccharomyces pombe (Fission Yeast). Mol. Cell. Proteomics 13, 1925\u20131936 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFncomms12304_CR47","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms12304_CR48","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome. Res. 10, 1794\u20131805 (2011).","journal-title":"J. Proteome. Res."},{"key":"BFncomms12304_CR49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2010.01.013","volume":"32","author":"CA Luber","year":"2010","unstructured":"Luber, C. A. et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32, 279\u2013289 (2010).","journal-title":"Immunity"},{"key":"BFncomms12304_CR50","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.4049\/jimmunol.0903022","volume":"184","author":"K Chen","year":"2010","unstructured":"Chen, K. et al. A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J. Immunol. 184, 3331\u20133335 (2010).","journal-title":"J. Immunol."},{"key":"BFncomms12304_CR51","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","volume":"44","author":"JA Vizcaino","year":"2016","unstructured":"Vizcaino, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44, D447\u2013456 (2016).","journal-title":"Nucleic Acids Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms12304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms12304","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms12304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:39:10Z","timestamp":1672810750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms12304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,25]]}},"alternative-id":["BFncomms12304"],"URL":"https:\/\/doi.org\/10.1038\/ncomms12304","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"assertion":[{"value":"1 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12304"}}